Skip to main content
NCBI home page
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1997;5(2):121–127. doi: 10.1155/S1064744997000197

Immunopathogenesis of Toxoplasmosis in Pregnancy

Jean Dupouy-Camet 1
PMCID: PMC2364566  PMID: 18476164

Abstract

The immunopathogenesis of toxoplasmosis during pregnancy is not completely understood. This paper will try to discuss the most frequently asked questions about the immunopathogeny of congenital toxoplasmosis: differential virulence of Toxoplasma isolates, genetic susceptibility to infection, facilitation of placental transfer, models of congenital toxoplasmosis, and transmission in seropositive hosts. Most published data suggest a role of the genetic background of the host and of the parasite. Models of congenital toxoplasmosis have been evaluated, but it appears that the conclusion drawn would be barely appropriate to understand the pathogenesis in pregnant women.

Full Text

The Full Text of this article is available as a PDF (658.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Araujo F., Slifer T., Kim S. Chronic infection with Toxoplasma gondii does not prevent acute disease or colonization of the brain with tissue cysts following reinfection with different strains of the parasite. J Parasitol. 1997 Jun;83(3):521–522. [PubMed] [Google Scholar]
  2. Brown C. R., McLeod R. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J Immunol. 1990 Nov 15;145(10):3438–3441. [PubMed] [Google Scholar]
  3. Candolfi E., Villard O., Thouvenin M., Kien T. T. Role of nitric oxide-induced immune suppression in toxoplasmosis during pregnancy and in infection by a virulent strain of Toxoplasma gondii. Curr Top Microbiol Immunol. 1996;219:141–154. doi: 10.1007/978-3-642-51014-4_13. [DOI] [PubMed] [Google Scholar]
  4. Dardé M. L., Bouteille B., Pestre-Alexandre M. Isoenzyme analysis of 35 Toxoplasma gondii isolates and the biological and epidemiological implications. J Parasitol. 1992 Oct;78(5):786–794. [PubMed] [Google Scholar]
  5. Deckert-Schlüter M., Schlüter D., Hof H., Wiestler O. D., Lassmann H. Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study. J Neuropathol Exp Neurol. 1994 Sep;53(5):457–468. doi: 10.1097/00005072-199409000-00005. [DOI] [PubMed] [Google Scholar]
  6. Deckert-Schlüter M., Schlüter D., Schmidt D., Schwendemann G., Wiestler O. D., Hof H. Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response. Infect Immun. 1994 Jan;62(1):221–228. doi: 10.1128/iai.62.1.221-228.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Desmonts G., Couvreur J., Thulliez P. Toxoplasmose congénitale. Cinq cas de transmission à l'enfant d'une infection maternelle antérieure à la grossesse. Presse Med. 1990 Sep 29;19(31):1445–1449. [PubMed] [Google Scholar]
  8. Formby B. Immunologic response in pregnancy. Its role in endocrine disorders of pregnancy and influence on the course of maternal autoimmune diseases. Endocrinol Metab Clin North Am. 1995 Mar;24(1):187–205. [PubMed] [Google Scholar]
  9. Fortier B., Aïssi E., Ajana F., Dieusart P., Denis P., Martin de Lassalle E., Lecomte-Houcke M., Vinatier D. Spontaneous abortion and reinfection by Toxoplasma gondii. Lancet. 1991 Aug 17;338(8764):444–444. doi: 10.1016/0140-6736(91)91064-2. [DOI] [PubMed] [Google Scholar]
  10. Gavinet M. F., Robert F., Firtion G., Delouvrier E., Hennequin C., Maurin J. R., Tourte-Schaefer C., Dupouy-Camet J. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol. 1997 May;35(5):1276–1277. doi: 10.1128/jcm.35.5.1276-1277.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Grimwood J., Smith J. E. Toxoplasma gondii: the role of parasite surface and secreted proteins in host cell invasion. Int J Parasitol. 1996 Feb;26(2):169–173. doi: 10.1016/0020-7519(95)00103-4. [DOI] [PubMed] [Google Scholar]
  12. Guo Z. G., Gross U., Johnson A. M. Toxoplasma gondii virulence markers identified by random amplified polymorphic DNA polymerase chain reaction. Parasitol Res. 1997;83(5):458–463. doi: 10.1007/s004360050280. [DOI] [PubMed] [Google Scholar]
  13. Gómez Marín J. E., Pinon J. M., Bonhomme A., Guenounou M. Does human toxoplasmosis involve an imbalance in T1/T2 cytokines? Med Hypotheses. 1997 Feb;48(2):161–169. doi: 10.1016/s0306-9877(97)90283-8. [DOI] [PubMed] [Google Scholar]
  14. Hennequin C., Dureau P., N'Guyen L., Thulliez P., Gagelin B., Dufier J. L. Congenital toxoplasmosis acquired from an immune woman. Pediatr Infect Dis J. 1997 Jan;16(1):75–77. doi: 10.1097/00006454-199701000-00018. [DOI] [PubMed] [Google Scholar]
  15. Hohlfeld P., Forestier F., Marion S., Thulliez P., Marcon P., Daffos F. Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mothers and fetuses. Pediatr Infect Dis J. 1990 Dec;9(12):878–881. doi: 10.1097/00006454-199012000-00004. [DOI] [PubMed] [Google Scholar]
  16. Howe D. K., Honoré S., Derouin F., Sibley L. D. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis. J Clin Microbiol. 1997 Jun;35(6):1411–1414. doi: 10.1128/jcm.35.6.1411-1414.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Howe D. K., Summers B. C., Sibley L. D. Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii. Infect Immun. 1996 Dec;64(12):5193–5198. doi: 10.1128/iai.64.12.5193-5198.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kasper L. H. Identification of stage-specific antigens of Toxoplasma gondii. Infect Immun. 1989 Mar;57(3):668–672. doi: 10.1128/iai.57.3.668-672.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Kasper L. H., Ware P. L. Recognition and characterization of stage-specific oocyst/sporozoite antigens of Toxoplasma gondii by human antisera. J Clin Invest. 1985 May;75(5):1570–1577. doi: 10.1172/JCI111862. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. European Collaborative Study and Research Network on Congenital Toxoplasmosis. Eur J Obstet Gynecol Reprod Biol. 1996 Sep;68(1-2):93–96. doi: 10.1016/0301-2115(96)02497-9. [DOI] [PubMed] [Google Scholar]
  21. Marty P., Bongain A., Rahal A., Thulliez P., Wasfi D., Lambert J. C., Le Fichoux Y., Gillet J. Y. Prenatal diagnosis of severe fetal toxoplasmosis as a result of toxoplasmic reactivation in an HIV-1 seropositive woman. Prenat Diagn. 1994 May;14(5):414–415. doi: 10.1002/pd.1970140514. [DOI] [PubMed] [Google Scholar]
  22. Maubert B., Guilbert L. J., Deloron P. Cytoadherence of Plasmodium falciparum to intercellular adhesion molecule 1 and chondroitin-4-sulfate expressed by the syncytiotrophoblast in the human placenta. Infect Immun. 1997 Apr;65(4):1251–1257. doi: 10.1128/iai.65.4.1251-1257.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. McLeod R., Skamene E., Brown C. R., Eisenhauer P. B., Mack D. G. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. J Immunol. 1989 Nov 1;143(9):3031–3034. [PubMed] [Google Scholar]
  24. Minkoff H., Remington J. S., Holman S., Ramirez R., Goodwin S., Landesman S. Vertical transmission of toxoplasma by human immunodeficiency virus-infected women. Am J Obstet Gynecol. 1997 Mar;176(3):555–559. doi: 10.1016/s0002-9378(97)70547-7. [DOI] [PubMed] [Google Scholar]
  25. Pons J. C., Sigrand C., Grangeot-Keros L., Frydman R., Thulliez P. Toxoplasmose congénitale: transmission au foetus d'une infection maternelle antéconceptionnelle. Presse Med. 1995 Jan 21;24(3):179–182. [PubMed] [Google Scholar]
  26. Roberts C. W., Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology. 1992 Feb;104(Pt 1):19–23. doi: 10.1017/s0031182000060753. [DOI] [PubMed] [Google Scholar]
  27. Roberts C. W., Cruickshank S. M., Alexander J. Sex-determined resistance to Toxoplasma gondii is associated with temporal differences in cytokine production. Infect Immun. 1995 Jul;63(7):2549–2555. doi: 10.1128/iai.63.7.2549-2555.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Schoondermark-Van de Ven E., Galama J., Camps W., Vree T., Russel F., Meuwissen J., Melchers W. Pharmacokinetics of spiramycin in the rhesus monkey: transplacental passage and distribution in tissue in the fetus. Antimicrob Agents Chemother. 1994 Sep;38(9):1922–1929. doi: 10.1128/aac.38.9.1922. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schoondermark-Van de Ven E., Melchers W., Camps W., Eskes T., Meuwissen J., Galama J. Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother. 1994 Sep;38(9):1930–1936. doi: 10.1128/aac.38.9.1930. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schoondermark-Van de Ven E., Melchers W., Galama J., Camps W., Eskes T., Meuwissen J. Congenital toxoplasmosis: an experimental study in rhesus monkeys for transmission and prenatal diagnosis. Exp Parasitol. 1993 Sep;77(2):200–211. doi: 10.1006/expr.1993.1077. [DOI] [PubMed] [Google Scholar]
  31. Schoondermark-van de Ven E., Galama J., Vree T., Camps W., Baars I., Eskes T., Meuwissen J., Melchers W. Study of treatment of congenital Toxoplasma gondii infection in rhesus monkeys with pyrimethamine and sulfadiazine. Antimicrob Agents Chemother. 1995 Jan;39(1):137–144. doi: 10.1128/aac.39.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Sher A., Denkers E. Y., Gazzinelli R. T. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. Ciba Found Symp. 1995;195:95–109. doi: 10.1002/9780470514849.ch7. [DOI] [PubMed] [Google Scholar]
  33. Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988 Apr 22;240(4851):516–518. doi: 10.1126/science.3128869. [DOI] [PubMed] [Google Scholar]
  34. Suzuki Y., Yang Q., Remington J. S. Genetic resistance against acute toxoplasmosis depends on the strain of Toxoplasma gondii. J Parasitol. 1995 Dec;81(6):1032–1034. [PubMed] [Google Scholar]
  35. Vogel N., Kirisits M., Michael E., Bach H., Hostetter M., Boyer K., Simpson R., Holfels E., Hopkins J., Mack D. Congenital toxoplasmosis transmitted from an immunologically competent mother infected before conception. Clin Infect Dis. 1996 Nov;23(5):1055–1060. doi: 10.1093/clinids/23.5.1055. [DOI] [PubMed] [Google Scholar]
  36. Walker W., Roberts C. W., Ferguson D. J., Jebbari H., Alexander J. Innate immunity to Toxoplasma gondii is influenced by gender and is associated with differences in interleukin-12 and gamma interferon production. Infect Immun. 1997 Mar;65(3):1119–1121. doi: 10.1128/iai.65.3.1119-1121.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wong S. Y., Remington J. S. Toxoplasmosis in pregnancy. Clin Infect Dis. 1994 Jun;18(6):853–862. doi: 10.1093/clinids/18.6.853. [DOI] [PubMed] [Google Scholar]
  38. Zenner L., Darcy F., Cesbron-Delauw M. F., Capron A. Rat model of congenital toxoplasmosis: rate of transmission of three Toxoplasma gondii strains to fetuses and protective effect of a chronic infection. Infect Immun. 1993 Jan;61(1):360–363. doi: 10.1128/iai.61.1.360-363.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES